-
Product Insights
NewDravet Syndrome (Severe Myoclonic Epilepsy of Infancy) – Drugs In Development, 2024
Empower your strategies with our Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) – Drugs In Development, 2024 report and make more profitable business decisions. Dravet syndrome, also known as severe myoclonic epilepsy of infancy, is a rare genetic disorder that causes a severe form of epilepsy. It usually starts in the first year of life with prolonged seizures triggered by fever or high temperature. Children with Dravet syndrome have various types of seizures that are difficult to treat with medications. They...
-
Product Insights
NewChildhood Epilepsy – Drugs In Development, 2024
Empower your strategies with our Childhood Epilepsy – Drugs In Development, 2024 report and make more profitable business decisions. Childhood epilepsy is a neurological disorder characterized by recurring seizures in children. Seizures result from abnormal electrical activity in the brain, causing temporary disruptions in behavior, awareness, sensation, or consciousness. This condition can manifest in various forms, from brief staring spells to convulsions or loss of consciousness. The causes of childhood epilepsy can vary, including genetic factors, brain injury, infections, developmental disorders,...
-
Analyst Opinions
Tech, Genes, and Beyond – Startup Transforming Biotech
Biotech Startups Overview Biotech breakthroughs drive cost savings, provide competitive advantages, and showcase efficiency across industries through streamlined manufacturing, custom product development, and resilient supply chains. Biotech advancements are also reshaping the fields of medicine, agriculture, and industry. The following are some of the key highlights of the biotech startups trend analysis: Startups are leading the way for biotechnology advancements. Healthcare demands, government support, and technological breakthroughs are driving the market. AI integration is driving progress in DNA sequencing, drug...
-
Case Studies
New Product Development Opportunities from the Rise of Solo Households
New Product Development Opportunities from the Rise of Solo Households Report Overview Rapid urbanization and economic migration are the key factors responsible for the increase in the rates of solo living across the globe. Individuals often migrate from rural to urban areas as a necessity for higher income opportunities, which often requires a change in living arrangements, such as solo housing. Also, higher rates of urbanization can be viewed as a proxy for wealth and greater economic opportunity in some...
-
Company Insights
American Express (Amex) – Digital Transformation Strategies
American Express Digital Transformation Strategies Report Overview American Express is leveraging emerging technologies as a part of its digital transformation strategies. The annual ICT spending of American Express was estimated at $2.4 billion in 2023. A major share of this spending is earmarked for acquiring software, ICT services, and hardware from vendors. American Express (Amex) is a provider of card products and travel-related services. It offers a range of credit cards, charge cards, and other payment and financing solutions to...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BL-001 in Epilepsy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BL-001 in Epilepsy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.BL-001 in EpilepsyDrug Details:BL-001 is under development for the treatment of epilepsy, Dravet Syndrome and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BL-001 in Amyotrophic Lateral Sclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BL-001 in Amyotrophic Lateral Sclerosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.BL-001 in Amyotrophic Lateral SclerosisDrug Details:BL-001 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SL-22P in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SL-22P in Solid Tumor report and make more profitable business decisions. How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LY-3537021 in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LY-3537021 in Type 2 Diabetes report and make more profitable business decisions. How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s...
-
Thematic Analysis
Batteries – Thematic Intelligence
Explore the following trends and insights from the ‘Batteries’ thematic report: Synopsis of the batteries theme and understand its progress over the past decade. Key trends impacting the growth of the theme over the next 12 to 24 months, namely, technology trends, macroeconomic trends, and regulatory trends. Multiple data sets, including patents and M&A trends, to set smart business goals. The report also provides a timeline highlighting milestones in the development of the batteries. Core segments of the value chain, including...